

ResMed (NYSE:RMD) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided...
You can purchase shares of ResMed (NYSE:RMD) through any online brokerage.
Other companies in ResMed’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
ResMed has a consensus price target of $251.76.
The stock price for ResMed (NYSE: RMD) is $240.525 last updated November 4, 2026 at 9:40 AM EST.
There are no upcoming dividends for ResMed.
ResMed does not have any upcoming earnings scheduled.
There is no upcoming split for ResMed.
ResMed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to...